
Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways
Balasa, Balaji, Yun, Rui, Belmar, Nicole A., Fox, Melvin, Chao, Debra T., Robbins, Michael D., Starling, Gary C., Rice, Audie G.Volume:
64
Langue:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-014-1610-3
Date:
January, 2015
Fichier:
PDF, 1.22 MB
english, 2015